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INTRODUCTION 
Chronic venous insufficiency (CVI) is a disease of the venous system of the lower limbs.  
It is a spectrum of conditions that affect the skin and subcutaneous tissue, with advanced  
stages manifesting as venous ulcerations. The Vein Consult Program evaluated more than  
91000 patients in different parts of the world and found a worldwide prevalence of CVI  
of 63.9% (1). It is the leading cause of ulcerations in the leg (2). Venous ulcers have an  
estimated prevalence of about 0.3%, although active or healed ulcers are seen in about  
1.0% of the adult population.(3) Venous ulcers are a major concern in health care system  
because of the morbidity associated with it and the huge socioeconomic impact that it has  
in terms of cost and most importantly, reduced quality of life that is associated with it.(4) 
Venous ulcers are difficult to heal requiring long term treatment and 97 percent of  
patients experience recurrent ulcers within ten years of developing the first ulcer.(5)  
A systematic review showed that venous ulcers, hence, have a negative impact on all  
aspects of daily living.(6) Lifestyle changes continue to play an integral role in the  
treatment of venous ulcers. Hence, much contemplation has gone into determining the  
factors which increase the risk of ulceration in patients with venous disease. This would  
help us identify patients who are at an increased risk of developing ulcers early, target  
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them and thus take appropriate measures to prevent the progression of the disease. 
Some of the risk factors that have been described for chronic venous insufficiency are older  
age, male sex, obesity, family history, history of phlebitis and previous leg injury. (7) The 
role of obesity is, however, controversial.  Some studies have shown that there is a positive  
correlation between body mass index and clinical severity of venous disease (8) and that 
being overweight is a separate risk factor for skin changes in venous disease. (9)  
However, there are other studies which have found no association between being  
overweight and ulceration in venous disease.(10)  Recent data suggests that obesity is a risk  
factor in females but not in males. (11) Most western studies that have looked at this  
aspect are descriptive studies with a few using suitable controls. Further, the population  
included in these studies had more cases with early disease as compared to the Indian  
population where we tend to see more patients with advanced forms of venous disease.  
Keeping the above facts in mind, this study is being planned to compare patients with  
venous ulceration to patients who have venous disease but no ulceration. 
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AIMS AND OBJECTIVES 
 
Aim 
 
The aim of this study is to assess the influence of Body Mass Index on the development 
of ulceration in patients with venous disease. 
 
 
Primary Objective  
To find out the association between Body Mass Index and venous ulcer. 
 
Secondary Objective  
To look at other factors which may contribute to ulceration in patients with venous 
insufficiency. 
 
Study Hypothesis 
Null Hypothesis states that there is no association between body mass index and ulceration 
in venous disease. 
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REVIEW OF LITERATURE 
HISTORY 
Venous valves were first described by the Parisian Charles Estienne as early as 1545 and 
demonstrated in cadaveric dissections by Lusitanus and Canano. However, it was sixty-
four years later that through the work of Fabricius ab Aquapendente that they were fully 
recognized.(12) It was finally in 1628 that the function of the venous valve was established 
via the discovery of blood circulation by William Harvey. 
 
DEFINITION 
Chronic venous disease refers to morphological and/ or functional abnormalities of 
the venous system of the lower extremities. 
Body Mass Index defined as a person's weight in kilograms divided by the square of his 
height in meters (kg/m2) 
WHO defines Overweight as a BMI greater than or equal to 25 and 
Obesity is a BMI greater than or equal to 30. 
However, for the Asia- Pacific region different cut offs have been recommended by WHO: 
Generalized Obesity was defined using the WHO Expert Consultation guidelines as BMI 
>= 25 kg m−2 (13) and Abdominal obesity as WC >= 90 cm for men and >= 80 cm for 
women.(14) 
13 
 
 
Figure 1. WHO guidelines for Body Mass Index 
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Figure 2. Asian cut-off for Body Mass Index 
 
EPIDEMIOLOGY 
Chronic venous insufficiency is a common disease all over the world. There are several  
prevalence studies that have been conducted in different parts of the world and it varies 
greatly depending on the population that is studied. The Vein Consult Program found a 
worldwide prevalence of CVI of 63.9%. The prevalence varies from 1- 40 % in females 
and 1- 17 % in males.(15) The reason for such varied numbers over the world is probably 
due to the difference in distribution of risk factors and the availability of technology to  
detect venous insufficiency amongst those who have not yet developed manifestations of 
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the disease. Venous ulcers affect approximately 0.3 % of the population.(16) The Bonn 
Vein study had 3072 subjects, of which 9.6 % did not have any manifestations of the 
disease, 59 % had reticular veins , 14.3 % had varicose veins, 13.5 % had edema and  
3.6%  had the final stages of the disease ranging from lipodermatosclerosis to active or  
healed ulcer.(17) 
There are as such no prevalence studies conducted in India. However, the magnitude of the 
problem is huge as is evident in the huge numbers that are seen in the Vascular outpatient  
department. There are many studies which have highlighted the impact of venous 
insufficiency, especially venous ulcers on the quality of life of an individual.(18) In the  
Indian setup quality of life is of paramount importance because it affects those from low 
socioeconomic status(19) and often results in a change of occupation. Chronic venous 
insufficiency places a huge financial burden on those affected. In the Western European 
countries and USA it accounts for 1-2 % of the health care budget.(20) The annual cost of 
venous ulcers has been estimated to be £400 to 600 million for the United Kingdom and  
$1 billion for the United States.(21)  The debilitation associated with venous ulcers arises 
from the chronicity and the recurrent nature of the disease. A study done in France,  
showed that it was the 8th most common cause of  hospitalization.(22)  It leads to loss of 
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time from work resulting in loss of wages and adds to the cost of overall treatment. In the 
United States, disability associated with venous ulcers leading to loss of productive work 
hours is estimated at 2 million workdays per year and early retirement in 12.5% of  
workers with venous ulcers.(23)  
Some of the risk factors for chronic venous insufficiency that have been studied are age, 
obesity, sex, family history, pregnancy, phlebitis, previous leg injury. 
If we look at obesity alone, worldwide obesity has more than doubled since 1980.  
According to WHO, in 2014, 39 % of the adults over 18 years of age were overweight 
and 13 % were obese.(24) Obesity has been associated with most of the non-
communicable diseases such as diabetes mellitus, hypertension, coronary artery disease, 
dyslipidemia, osteoarthritis and any others.(25) Morbid obesity is only second to cigarette 
smoking as the underlying cause of death in the United States.(26) It is not just the 
amount of fat but the distribution of fat that influences the risk of developing any of the 
above conditions. Asian Indians are more predisposed to accumulation of visceral fat, 
truncal and abdominal obesity. Hence, Indians are more likely to develop life style 
related diseases, at a lower body mass index compared to their Caucasian counterparts. 
The Chennai Urban Rural Epidemiology Study (CURES) conducted in Chennai city in 
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Tamil Nadu reported the prevalence of obesity to be as high as  45.9 %.(27) What 
remains unclear is if obesity is by in itself an etiological factor for chronic venous 
insufficiency or it merely worsens the severity of venous reflux and hence, exacerbates 
the disease.  Hence, its role in chronic venous insufficiency needs to be studied.  
 
ANATOMY AND PHYSIOLOGY 
The venous system of the lower limb consists of the superficial, deep and perforator veins. 
 
 
             Figure 3. Relationship between the fascia and veins of the lower extremity 
The fascia covers the muscle and separates the deep from the superficial 
compartment. Superficial veins (a) drain the subpapillary and reticular venous 
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plexuses and they are connected to deep veins through perforating veins (b). The 
saphenous fascia invests the saphenous vein. The saphenous compartment is a 
subcompartment of the superficial compartment- Used with permission.(28) 
 
Superficial Veins 
The superficial veins of the lower limb include an interconnecting network of veins, the 
great and the short saphenous veins, and several accessory veins. They lie in the superficial 
fascia and over the surface of the deep muscular fascia. They have valves to regulate the 
direction of blood flow. Blood drains into the deep veins through the perforating veins. 
Deep veins 
These are the anterior and posterior tibial, peroneal, popliteal, femoral veins and their 
tributaries. They serve as the outflow tracts for the extremities. Blood flows to the heart 
through the deep veins. The unidirectional flow is maintained by the valves, especially in 
the upright posture. 
Perforating veins 
The perforator veins connect deep and superficial veins. The long saphenous gives rise to 
perforators. These are called indirect perforators. They tend to be randomly distributed. 
They may also arise from the accessory branches of long saphenous. Perforators connect 
reticular veins directly to the deep system. There are called the direct perforators. 
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Figure 4. Anatomy of the lower extremity  
A. Superficial veins & perforators, anterior view B. Superficial veins, posterior 
view C. Deep veins, anterior view(29) 
 
Effective venous return is maintained by adequate action of the central venous pump, 
pressure gradient, the peripheral venous pump and competent valves. The valves break the 
hydrostatic column of blood into segments and prevent retrograde flow. Thus, in 
coordination with the pump action of the calf muscles they prevent stasis of blood in the 
lower limb veins.  
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PATHOPHYSIOLOGY OF CHRONIC VENOUS INSUFFICIENCY 
Chronic venous insufficiency results from ambulatory venous hypertension. This could be 
due to venous reflux due to valvular incompetence, or due to venous outflow obstruction 
or muscle pump dysfunction. Valvular dysfunction can be due to primary weakness of the 
vessel wall or valve leaflets or secondary to venous distension or superficial phlebitis. 
Venous obstruction can be intrinsic due to deep vein thrombosis or because of extrinsic 
compression.(23)  
The venous hypertension causes remodeling of the venous wall (30) and activates 
endothelial and smooth muscle cells initiating a cascade of inflammatory pathways.(31) 
There is overexpression of adhesion molecules which activates leucocytes and leads to 
release of chemotactic factors (factor VIII-related antigen, endothelial leukocyte adhesion 
molecules (ELAM-1). This causes further accumulation of white blood cells and 
subsequently damages the capillary endothelium causing increased capillary permeability. 
This was proposed as the white cell trapping theory.  
The activated leucocytes release chemokines, cytokines, growth factors, proteases and 
proteins which lead to persistent inflammation and skin changes and venous ulceration.(32) 
Fibrinogen gets leaked out and forms a fibrin cuff (33) causing ischemia of the skin and 
the other skin manifestations that are seen in venous insufficiency. This is called the fibrin 
cuff theory.  
There are still a lot of study going on to understand the biochemical, molecular and genetic 
alterations that play a role in the pathophysiology of chronic venous insufficiency. 
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However, is the pathophysiology for chronic venous insufficiency the same amongst the 
obese? There is data to show that healing rates are slower for venous ulcers amongst the 
obese and also that they are more likely to recur. (34) There are many theories that have 
been proposed to explain this phenomenon. In the obese there is an increased intra-
abdominal pressure which is contributed to by the abdominal wall and the fat in the pelvis 
which probably causes compression of the veins, impairs venous return, thereby, increasing 
femoral venous pressures and contributing to reflux.(35) However, the calf muscle pump 
action is better in the obese. Contrary to this theory, in a study done by Padberg et al two 
– thirds of the obese subjects included in the study did not have any anatomic evidence of 
venous disease, neither reflux nor obstruction.(36) Hence, a combination of lymphovenous 
hypertension has been proposed as a possible pathophysiology behind venous insufficiency 
amongst the obese.  
 
CLINICAL PRESENTATION 
The term chronic venous insufficiency encompasses a spectrum of skin changes. The 
presenting symptoms are usually pain, heaviness of legs, edema, increased pigmentation 
and in severe cases recurrent non healing ulcers. 
CVI is classified according to the CEAP (clinical, etiologic, anatomic, pathologic) 
classification. It grades CVI on the basis of clinical symptoms and manifestations, etiology,  
anatomy, and pathophysiology. (37)  
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The higher the class, the more severe the symptoms and the patient’s disability. The CEAP 
classification is a dynamic classification and can change with the patient’s subsequent 
visits. 
CEAP classification (38) 
Clinical Classification 
C0 – Implies no Venous Disease 
 
C1 - Telangiectasia or Reticular Veins – Dilated subdermal veins 1 mm to less than 3 mm 
in diameter or a confluence of intradermal venules less than 1 mm, also called spider veins. 
Can present as ankle or malleolar flare called corona phlebectatica. 
 
Figure 5. C1 Stage 
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C2 - Varicose Veins – Dilated tortuous veins more than 3 m in diameter measured in the 
upright position. These are usually seen along the territory of great and short saphenous 
veins and their tributaries. 
 
Figure 6. C2 Stage  
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C3 - Presence of edema – in the skin and subcutaneous tissue which indents to pressure. 
Edema predominantly occurs around the ankles, however, can involve the foot and leg too. 
 
Figure 7. C2 and C3 Stage 
 
C4 – Secondary changes in skin and subcutaneous tissue. It is further subdivided into two 
based on severity. 
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C4a - Pigmentation or Eczema – Erythematous dermatitis with scaly eruptions and blister 
formation with serous discharge 
C4b – Lipodermatosclerosis – Chronic inflammation of skin and subcutaneous tissue 
which is localized. In early stages it can present with painful inflammatory edema. 
However, there will be absence of local inflammatory signs as seen in cellulitis and 
absence of any systemic sepsis. It progresses to brawny edema and fibrosis of skin and 
subcutaneous tissue causing scarring and contractures. Pigmentation maybe present as a 
result of extravasated blood.  Atrophie Blanche is a localized whitish discolouration and 
atrophic area of skin surrounded by dilated capillaries and hyperpigmentation.   
 
Figure 8. C4 Stage 
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C5 - Healed venous ulcer 
 
Figure 9. C5 Stage  
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C6 - Active Venous Ulcer 
 
Figure 10. C6 Stage 
 
Each clinical class is further characterized by a subscript for the presence of symptoms 
(S, symptomatic) or absence of symptoms (A, asymptomatic). The symptoms that 
patients usually present with are aching kind of pain with heaviness in the limb which is 
usually precipitated after prolonged standing, skin irritation, itching, mild bleeding and 
muscle cramps. 
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Etiologic Classification 
Ec - Congenital 
Ep - Primary 
Es -Secondary (post-thrombotic) 
En - No venous cause identified 
Anatomic classification 
As- Superficial veins 
Ap - Perforator veins 
Ad - Deep veins 
An - No venous location identified 
Pathophysiologic classification 
Pr - Reflux 
Po - Obstruction 
Pr,o - Reflux and obstruction 
Pn - No venous pathophysiology identifiable 
Advanced CEAP 
Same as Basic with the addition that any of 18 named venous segments can be utilized as 
locators for venous pathology:  
 
Superficial veins:  
1. telangiectasies/reticular veins.  
2. GSV above knee.  
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3. GSV below knee.  
4. LSV.  
5. Nonsaphenous veins.  
 
Deep veins:  
6. IVC.  
7. Common iliac vein.  
8. Internal iliac vein.  
9. External iliac vein.  
10. Pelvic: gonadal, broad ligament veins, other.  
11. Common femoral vein.  
12. Deep femoral vein.  
13. Femoral vein.  
14. Popliteal vein.  
15. Crural: anterior tibial, posterior tibial, peroneal veins (all paired).  
16. Muscular: gastrocnemial, soleal veins, other.  
 
Perforating veins:  
17. Thigh  
18. Calf. 
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RISK FACTORS  
Some of the risk factors that have been proposed for chronic venous insufficiency are older 
age, obesity, family history, history of deep vein thrombosis, smoking, prolonged standing 
and previous leg injury.(7) (39) 
 Age 
Older age has been found to be associated with higher C stage in the CEAP classification 
and also with an increased risk of progression of disease to ulceration. (9,40) 
 Sex 
While classically female sex has been thought to be associated with higher incidence of 
varicose veins (10), there are studies which have found that the male sex is more 
predisposed to venous insufficiency and ulceration. (7) 
 Deep vein thrombosis and History of injury to the limb 
Previous history of deep vein thrombosis increases the incidence of advanced stages of 
disease and ulceration.(7,41) The thrombus causes obstruction to the venous flow causing 
secondary dilatation and vavlular incompetence.(42) Post thombotic venous valve 
destruction is one of the leading causes of venous insufficiency. History of serious leg 
injury in the past is associated with higher predisposition to develop venous insufficiency. 
(43) Past history of injury or phlebitis results in a 2.4-fold and 25.7-fold increase in risk 
for chronic venous insufficiency.(7) 
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 Family history and genetics 
There are studies which have shown that a family history of venous insufficiency is 
associated with advanced stages of the disease. (44) There is a genetic predisposition to 
varicose veins. In a prospective study of 402 patients, the risk of developing varicose veins 
was 90% if both parents were affected. The risk was 25% for males and 62% for females 
if one parent was affected, and 20% if neither parent was affected. The above data 
suggested an autosomal dominant trait with variable penetration.(29,45)  
 Height 
In a study conducted in India, in rural Wardha among patients with chronic venous 
insufficiency it was seen that increase in height is responsible for 12.9% increase in 
saphenous venous diameter in supine position and 11.9% increase in saphenous venous 
diameter on Valsalva maneuver. (46) 
 Prolonged standing and Sedentary lifestyle 
It has been suggested that prolonged periods of standing lead to venous insufficiency. This 
is due to increased hydrostatic pressure which impedes blood flow and leads to venous 
stasis. However, the evidence for this association is quite conflicting. (44,47,48) 
 Smoking 
There are very few studies that have looked at the association between smoking and venous 
disease. While studies have shown that it might not be associated with higher risk of venous 
reflux (39), there are case control studies that have found that subjects who had smoked at 
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some point in life were twice more likely to develop venous ulcers compared to those that 
had never smoked. (49,50) 
 Pregnancy 
Multiparity has been associated with varicose veins in pregnant women. (40) 
 Obesity 
The role of obesity in chronic venous insufficiency is controversial. The increased intra-
abdominal pressure influences the lower limb venous hemodynamics(35,51) and raises 
venous pressures by causing reduced venous outflow, stasis and worsens venous reflux. 
(52) However, the muscle pump action is found to be better in the obese.(53) There are 
studies that have found a significant association between higher body mass index and 
advanced clinical disease as per the CEAP classification.(9,54,55) Some data however, 
suggests that this association is seen only in women and not in men.(11,56) Increased waist 
circumference by itself has been found to be a risk factor for severe venous disease. (44) 
However, Danielsson et al (8) found that this association was irrespective of the venous 
reflux parameters. In a study by Padberg et al, two- thirds of the subjects with severe venous 
disease and obesity did not have any anatomic evidence of disease at all. (36) The Bonn 
vein study and some others found no association between obesity and venous reflux in the 
superficial or deep venous system (57,58) whereas, in other studies there was some 
correlation between increasing body mass index and reflux only for women. (9,47) This 
suggests that even though there might be an association between body mass index and 
venous ulceration the pathophysiology behind it might not be as has been proposed. In 
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patients who have venous disease there is data which shows that obesity is associated with 
progression of disease to ulceration. (8,/34,44) Amongst the obese, venous ulcers heal 
slowly and have been found to be recurrent, adding to the morbidity of the disease. On the 
other hand there are studies which did not show any association between severity of disease 
and obesity. (3,59–63)  
 
DIAGNOSIS 
HISTORY AND CLINICAL EXAMINATION 
A detailed history of symptoms and clinical examination will help assess the clinical stage 
of the disease. History of possible risk factors and lifestyle of the patient should also be 
taken. Documentation of the disability and quality of life will also help direct the treatment 
plan. Differential diagnosis should be considered and other causes like arterial, rheumatoid, 
neurological and infectious must be excluded. (29) 
Patient has to be examined in supine and upright positions for signs of venous disease and 
the anatomical regions involved. It can then be classified according to the CEAP 
classification. In upright position there will be maximal venous distension. Inspection, 
palpation and auscultation for bruits form the essential steps of clinical examination. 
On palpation, two clinical tests are commonly used to locate the incompetent valve.  
 Brodie Trendelenberg Test- With the patient in the recumbent position, the leg is 
raised, once the tourniquet is applied just below the sapheno femoral junction. The 
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leg is then lowered by asking the patient to stand. If the superficial veins fill rapidly 
it indicates valvular incompetence below the level of the tourniquet in the deep or 
communicating veins. After 20 seconds, if there has been no rapid filling, the 
tourniquet is released. If there is sudden filling at this point, it indicates that the deep 
and communicating veins are competent but the superficial veins and the sapheno-
femoral valve are incompetent. 
The test can be repeated with the tourniquet above the knee to assess the mid thigh 
perforators and below the knee to assess incompetence between short saphenous 
vein and popliteal vein different levels to further pinpoint the level of valvular 
incompetence. However, this test is obsolete now. (64)  
 Perthe’s Test - The subject is made to lie in the supine position. Then the veins are 
milked after lifting the limb and tourniquet is applied in the upper thigh. Following 
this the patient is asked to ambulate. On walking if the veins dilate and engorge, it 
indicates incompetent perforators.  
 
Clinical Severity : 
The American Venous Forum committee developed the Venous Severity Scoring System 
in 2000, as a tool to assess the severity of the disease. It includes the Venous Disability 
Score, the Venous Segmental Disease Score and the Venous clinical Severity Score. The 
Venous Clinical Severity Score was based on the CEAP classification and has further been 
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revised to use as tool to assess the response of the disease to treatment. (65) It is a clinical 
tool based on history and examination of the patient. 
Revised Venous Clinical Severity Score 
- Pain or other discomfort (i.e. aching, heaviness, fatigue, soreness, burning) of 
venous origin 
 
None:         0  
Mild :         1  - Occasional pain or other discomfort (i.e. not restricting regular daily                
activities) 
Moderate : 2  - Daily pain or other discomfort (i.e. interfering with but not preventing   
regular daily activities) 
Severe :     3   - Daily pain or discomfort (i.e. limits most regular daily activities) 
- Varicose Veins 
None:          0  
Mild :          1  - Few, scattered. Also includes corona phlebectatica (ankle flare) 
Moderate : 2  - Confined to calf or thigh 
Severe :     3   - Involves calf and thigh 
- Venous edema 
None:          0  
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Mild :          1  - Limited to foot and ankle area 
Moderate :   2  - Extends above ankle but below knee 
Severe :        3  - Extends to knee and above 
- Skin pigmentation 
It does not include local pigmentation over the varicose veins or pigmentation due to other 
chronic disease 
None:.           0  
Mild :            1  - Limited to perimalleolar region 
Moderate :   2  - Diffuse over lower third of calf 
Severe :         3  - Wider distribution above the lower third of calf 
- Inflammation 
None:.           0  
Mild :            1  - Limited to perimalleolar region 
Moderate :   2  - Diffuse over lower third of calf 
Severe :         3  - Wider distribution above the lower third of calf 
- Induration – of venous origin with secondary skin and subcutaneous changes 
None:.           0  
Mild :            1  - Limited to perimalleolar region 
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Moderate :   2  - Diffuse over lower third of calf 
Severe :         3  - Wider distribution above the lower third of calf 
- Active ulcer number 
None:.           0  
Mild :            1  - 1 
Moderate :   2  - 2 
Severe :         3  - >= 3 
- Active ulcer duration 
None:.           0  
Mild :            1 - < 3 months 
Moderate :   2  - > 3 months but less than one year 
Severe :         3  - > 1 year 
- Largest active ulcer size (diameter) 
None:.           0  
Mild :            1 - < 2 cm 
Moderate :   2  - 2 – 6 cm 
Severe :         3  - > 6 cm 
- Use of compression therapy 
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None:.           0 – Not used 
Mild :            1 – intermittent use of stockings 
Moderate :   2  - wears stockings on most days 
Severe :         3  - Full compliance 
 
NON INVASIVE TESTING 
Venous Duplex Imaging 
Venous duplex imaging is the recommended first diagnostic investigation for Chronic 
venous disease and is the reference standard to assess the anatomy and haemodynamics of 
the lower limbs.(66) The superficial and deep venous system is assessed by B mode 
ultrasonography and a pulsed Doppler to assess the direction of flow. The components of 
a Duplex scan are anatomical and morphological information of the superficial and deep 
veins, compressibility, assess flow which includes reflux and augmentation with a cuff or 
valsalva. The cut off value for lower limb venous incompetence is 1 second for femoral 
and popliteal veins and 500 ms for saphenous, tibial, deep femoral and perforators.(67) It 
is however, important to correlate the findings with the clinical picture of the patient.  
Plethysmography 
Strain gauze or Air Plethysmography is used as an adjunct to Duplex scan because of its 
ability to quantify the pathophysiological component responsible for the venous 
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insufficiency in that particular patient whether it is reflux, obstruction or calf muscle pump 
dysfunction. This test is performed by application of a cuff around the calf. The patient is 
made to do exercises to empty and fill the veins. Displacement of air in the cuff volume is 
representative of the change in the volume of the leg which reflects the venous capacity 
and drainage.(68) Photoplethysmography is based on the ability of a probe to detect 
infrared light scattered back by haemoglobin during refill of veins once they are emptied 
and is used to assess the venous refill time. 
Computed Tomography or Magnetic Resonance Venography  
These are higher modalities of assessment of venous anatomy which are not commonly 
used due to the higher costs involved. Intravenous contrast is used in the study which 
helps to identify lesions which are causing intraluminal obstruction or extrinsic 
compression especially in the involvement of the pelvic veins. (23) 
  
INVASIVE TESTING 
Phlebography or Contrast Venography 
In complicated cases of recurrent varicose veins, venous malformations or in those with 
post thrombotic syndrome when alternative imaging may be inconclusive a venography 
can be done to delineate the anatomy. It helps distinguish between primary and secondary 
venous pathology.   
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Ambulatory Venous Pressure 
Ambulatory venous pressure monitoring is the gold standard to assess the hemodynamics 
in the superficial and deep venous system and to specify the severity of the disease. For 
measuring ambulatory venous pressure, a needle is injected into a lower limb vein and 
connected to a pressure transducer. The mean ambulatory pressures and refill time are 
monitored in the upright posture and then after applying an ankle cuff.(23) 
Intravascular Ultrasound 
Intravascular ultrasound is used in cases with suspected iliac vein obstruction or 
compression to look for lesions which cannot be identified on a contrast venography. It is 
also used to document post stenting resolution of stenosis and to confirm the position of 
the stent in the specific venous segments. (69) 
 
TREATMENT 
Goals of treatment are symptomatic relief, prevention of complications and in case of 
ulcers to promote healing and prevent recurrence. 
Lifestyle modifications 
This includes weight reduction, exercise, avoid prolonged standing and restrictive clothing, 
to stop smoking and reduce peripheral edema.(70) 
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Medical management  
Compression Therapy  
Compression therapy is the mainstay of treatment for chronic venous insufficiency and the 
most important therapy that promotes healing in venous ulcers. The aim is to provide 
adequate graded external compression to oppose the venous hypertension and reduce the 
edema. It can be done with bandages, compression stockings or pneumatic compression 
devices.  
Bandages: Single or multi component, elastic, extensible or inelastic short stretch bandages 
are also available. Multicomponent four layer bandaging provided the highest sustained 
pressure for the longest time. It can be assembled from individual components but is also 
available as a commercial kit. 
A meta- analysis of Randomized Control Trials comparing four layer bandages with short 
stretch bandages found that four layer bandages are associated with significantly shorter 
healing time. (71) 
Graduated elastic compression stockings are commonly used. Compressive stockings 
provide graded external compression of the leg which opposes the hydrostatic forces of 
venous hypertension. They are noninvasive and easy to use. They provide maximum 
pressure at the ankle : 
Class 1 : 14- 17 mm of Hg 
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Class 2 : 18 -24 mm of Hg 
Class 3 : 25 – 35 mm of Hg  
Class 4 : 49 – 70 mm of Hg 
Class 2 stockings are commonly used for venous ulcers. A meta-analysis of eight 
randomized control trials has shown that compression stockings are more effective than 
bandages. 
Intermittent pneumatic compression devices with eight or twelve chambers provide gradual 
increase in compression pressure. However, because of the costs involved it is usually a 
hospital based therapy. 
In patients with C6 disease, graded compression stockings and other compressive 
bandaging modalities can achieve healing of ulcers in more than 90 percent cases at a mean 
of 5.3 months(72) and also help in preventing recurrences. (73) 
 
Limb elevation and Physiotherapy 
Limb elevation has shown to reduce venous stasis, venous pressures and swelling of the 
limb. Thereby, leading to symptomatic relief and promoting healing of ulceration. Reduced 
ankle joint mobility has been associated with non healing of ulceration. (74) Physiotherapy 
re-establishes calf muscle pump function and helps ankle joint mobility. 
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Wound and Skin Care 
Aggressive wound care and daily dressings to manage the skin changes. Special dressings 
are also available like hydrocolloid, foam and silver impregnated dressings.   
Pharmacologic Therapy 
Venoactive drugs like coumarins (α-benzopyrones), flavonoids (gamma benzopyrones), 
saponosides (horse chestnut seed extracts), and micronized purified flavonoid fraction have 
shown to increase venous tone and reduce capillary permeability. Flavonoids act on 
leukocytes and endothelium and result in decreased inflammation and permeability and 
hence reduce edema. Pentoxifylline has also been tried to promote faster healing in venous 
ulcerations.(75) 
Bisgaards regimen  
This the mainstay for the management of venous ulcers. It was four components : 
i. Exercise – Range of motion exercises for the ankle including plantar flexion and 
dorsiflexion are essential for the calf pump action. Ankle fibrosis leading to a fixed 
ankle delays and prevents the healing process in venous ulcers. 
ii. Elevation of the limb and rest 
iii. Dressings – Daily dressings of the venous ulcers promote healing. There are 
multiple dressing materials that have been described, however, simple saline 
dressings are also equally effective. 
iv. Compression  
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Interventional Management 
Sclerotherapy 
It is used for obliterating the small and medium veins which are less than 5 mm.  A needle 
is inserted in the vein and a sclerosant most commonly sodium tetradecyl sulphate is 
injected which reacts with the endothelium of the vein and scars the vein. Other sclerosants 
used are glycerin, polidocanol and sodium morrhuate. (76) It is an easy procedure to do 
and is cost effective. 
Endo-venous Ablation 
Endo-venous ablation converts thermal energy into radiofrequency or laser which causes 
thermal injury to the vein wall leading to thrombosis and fibrosis. In radiofrequency 
ablation of the great saphenous vein there is complete obliteration in 85% after two years 
with recanalization in 11%.(77) Complications include pulmonary embolism and deep vein 
thrombosis. 
Endo-venous Deep System Therapy 
10% to 30% of patients with severe CVI have abnormality in venous outflow involving 
iliac vein segments leading to persistent symptoms. Several series of patients with CVI and 
evidence of outflow obstruction found that iliac vein stenting led to clinical improvement. 
(29)  
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Surgical intervention 
Ligation Stripping and Venous Phlebectomy 
It involves removal of the saphenous vein with high ligation of the sapheno-femoral 
junction. Large varicose clusters that communicate with the incompetent saphenous vein 
can be avulsed at the same setting by stab phlebectomy. 
Ligation and stripping of the great saphenous eliminates deep venous reflux, gives 
symptomatic relief, and aids in ulcer healing.  
Subfascial Endoscopic Perforator Surgery 
For ligation of incompetent perforator veins access is obtained from a site distant from the 
ulcerated and necrotic skin, since incision over the compromised skin may lead to wound 
complications.  
Valve Reconstruction  
Venous valve reconstruction of the deep vein valves has been performed in selected 
patients with advanced CVI who have recurrent ulceration with severe and disabling 
symptoms.  
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METHODOLOGY 
 
 FUNDING AND APPROVAL 
This study was approved by IRB Min. No. 9739 dated 10.11.2015 (Annexure 3) 
Funding for the study was given by the Fluid Research Grant. (Annexure 4) 
 
STUDY DESIGN 
This study was a prospective case control study. 
We have adhered to the Strobe guidelines as specified for a case control study.  
(Annexure 5)  
 
SETTING  
The study was conducted at the Vascular Surgery Outpatient department of Christian 
Medical College, Vellore.  
Subjects for the study were recruited from January, 2016 to June, 2017.  
 
PATIENT POPULATION 
All patients who presented to the Vascular Surgery Outpatient Department of Christian 
Medical College, Vellore with a documented venous insufficiency using a duplex scan 
were enrolled into the study after signing an informed consent. The patients who 
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presented to the outpatient department and were recruited were predominantly from West 
Bengal, Tamil Nadu, Andhra Pradesh and Bangladesh. 
 
 
       Figure 11. Map with the states of origin of the patient population highlighted 
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INCLUSION CRITERIA 
 
Cases  
All patients with documented venous insufficiency using a duplex scan who presented to 
vascular surgery outpatient department, CMC Vellore, and had an active or healed ulcer. 
Controls  
All patients with documented venous insufficiency using a duplex scan who presented to 
vascular surgery outpatient department, CMC Vellore, and did not have 
an active or healed ulcer.  
 
Rationale for choosing controls : Choosing controls who also have venous disease but no 
ulceration as compared to the normal population would help eliminate confounding 
factors which play a role in the development of venous disease but not necessarily 
leading to progression of disease.   
 
EXCLUSION CRITERIA 
• All patients with congenital vascular malformations 
• All patients with C0-C1 disease 
• All patients with ulcers due to causes other than chronic venous disease 
• Patients with acute deep vein thrombosis 
• Patients not advised duplex scanning 
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DIAGNOSTIC TOOL 
All the patients who were recruited had a documented venous Doppler confirming venous 
insufficiency. 
The venous Doppler scans of bilateral lower limbs were done in the Department of 
Radiology, CMC Vellore in TOSHIBA Xario ultrasound machine. The scans were done 
by radiologists with a minimum of two months experience in Doppler scans.  
The entire study consisted of two parts – 
1. To assess the presence or absence of deep venous thrombosis in the abdominal and 
lower limb venous system.  
2. To assess the presence or absence of venous insufficiency in the lower limbs.  
The first part of the study was done with the patient in lying down position.  
The following veins were assessed for the presence of venous flow and phasicity : 
1. Infra renal IVC 
2. Bilateral common iliac veins  
3. Bilateral external iliac veins  
The following veins of the lower limbs were assessed for presence of venous flow, 
phasicity and the presence of augmentation response. Augmentation response is a 
characteristic feature seen in the venous system of the limbs where in the application of a 
compressive force results in an augmented response in the draining vein.  
1. Bilateral common femoral veins 
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2. Bilateral superficial femoral veins in the proximal, mid and distal parts  
3. Bilateral popliteal veins  
4.  
5. 
Figure   . Chronic thrombus in left Popliteal vein 
 
The second part of the study was done in standing position.  
To demonstrate the presence or absence of venous reflux, the patient was asked to 
perform the “valsalva” maneuver and during that period the venous flow was assessed. If 
reversal of venous flow was present for more than 600 ms a positive venous reflux was 
considered.  
The bilateral sapheno-femoral and sapheno-poppliteal junction (if formed) were assessed 
for the presence or absence of venous reflux and there by assessing whether these were 
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competent or not. The diameter of the sapheno-femoral and sapheno-popliteal junction 
were also measured.  
 
Figure   . Right Sapheno-femoral Junction incompetence 
 
The presence of deep venous reflux was assessed in the bilateral common femoral veins, 
superficial femoral veins and popliteal veins. 
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Figure   . Deep venous reflux in Superficial Femoral Vein 
Figure   . Deep venous reflux in left Popliteal Vein 
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The great saphenous vein and the short saphenous vein were also measured.  
The perforators in each of these venous territories were assessed for presence of flow 
reversal and a note of the diameter of the perforator was made. Perforators were assessed 
in the medial, lateral and posterior aspects of the calves bilaterally. If there was no 
reversal of venous flow in the perforators in neutral position, then the patient was asked 
to keep the foot in dorsiflexed position and flow reversal was assessed.  
 
Figure   . Perforator incompetence 
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The final report given detailed the  
- presence or absence of deep vein thrombosis 
- presence or absence of venous insufficiency 
If venous insufficiency was present, then the venous territory was mentioned and the 
etiology, whether perforator or junction incompetence or both was mentioned.  
 
VARIABLES 
Outcome:  Presence of an active or healed ulcer caused due to venous insufficiency. 
Exposure: “Overweight” as defined by the WHO criteria a BMI of 25 to 29.99 and 
“Obese” a BMI of 30 or more. Diagnosis of venous disease will be done using a Venous 
Duplex 
 
DATA SOURCES AND MEASUREMENT 
Enrolled patients were clinically examined in the Out Patient Clinic using the Clinical, 
Etiological, Anatomical and Pathophysiological (CEAP) classification. The clinical grade 
of venous disease of the patients was documented for each limb.  
Limbs were classified as: 
 C0: no visible or palpable signs of venous disease 
 C1: telangiectasies or reticular veins 
 C2: varicose veins 
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 C3: edema 
 C4a: pigmentation and eczema 
 C4b: lipodermatosclerosis and atrophie blanche 
 C5: healed venous ulcer 
 C6: active venous ulcer 
130 patients with C5 or C6 disease were enrolled as cases and another 130 patients with 
C2 to C4 disease were enrolled as controls.  
All cases and controls were subjected to a questionnaire, which was directed to look at 
factors which predispose a patient with venous disease to ulceration.  
The height and weight of each of the cases and controls was measured by using 
standardized instruments. 
Height was measured to the nearest 5mm without shoes. 
Weight was measured to the nearest 100 g on a digital scale without shoes. 
Body Mass Index was calculated as person's weight in kilograms divided by the square of 
his height in meters (kg/m2). 
Venous Doppler findings were taken from the electronic data records of patients.  
 
BIAS 
Using a case control design helped to reduce potential confounders.  
We also tried to enrol contiguous patients to help reduce selection bias. 
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SAMPLE SIZE 
Estimated sample size for two-sample comparison of means 
Test Ho: m1 = m2, where m1 is the mean in population 1 and m2 is the mean in 
population 2 
Assumptions: 
alpha = 0.0500 (two-sided) 
power = 0.8000 
m1 = 31.7 
m2 = 29.1 
sd1 = 8.4 
sd2 = 6.4 
n2/n1 = 1.00 
Estimated required sample sizes: 
n1 = 130 
n2 = 130 
Reference : 
Robertson L et al. Risk factors for chronic ulceration in patients with varicose veins: 
a case control study. J Vasc Surg. (2009) (49) 
 
 
57 
 
FLOW CHART 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
 
 
 
 
 
 
 
 
Assess for eligibility on the basis of 
Venous Duplex 
 
 
‘ a 
 (n = …) 
Excluded : 
Not meeting inclusion criteria 
Refused to participate 
C0 and C1 disease 
Congenital vascular malformations 
Other causes of ulceration 
Acute DVT 
Those not advised a duplex scan 
 
      Take consent 
Allocated to cases:  C5- C6 
disease (n =130) 
 
 
 
 
Allocated to controls : C2 - C4 
disease  (n =130) 
 
 
Study questionnaire 
-  Patient demographics 
           -  Risk factors 
Clinical Examination using CEAP classification 
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STATISTICAL METHODS 
Data from the case report form was entered into the Epidata v 3.1 data entry software and 
then exported to SPSS. The analysis was performed by trained biostatisticians. 
Data was summarized as mean ± SD / median (range) for continuous variables, frequency 
along with percentage for categorical variables. Independent t-test was used to compare 
the continuous variables among the case and control. Similarly the Chi-square test was 
performed to compare the categorical variables among the case and control. The estimate 
of effect size were presented as odds ratio (95% CI). A multiple logistic regression was 
performed to analyse the adjusted effect of variables over the case and control. The 
goodness of fit was tested using Hosmer-lemshow test and McFadden’s R square was 
reported. Additionally the continuous variables among the BMI subgrouping was 
analyzed using ANOVA/ Kruskal-wallis test based on the normality along with pairwise 
comparison, the categorical variables were compared using chi-square test. 
All the analysis were performed using STATA I/C 13.1 
Check Body Mass Index 
Analysis 
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RESULTS AND ANALYSIS 
269 patients were recruited for the study. Out of which 9 were excluded – 4 patients had 
C1 disease and 5 patients did not have a venous Duplex. A total of 130 cases with C5 or 
C6 disease and 130 controls with C2 to C4 disease were analyzed. All of them had a 
documented venous duplex showing venous insufficiency. 
Category Number of patients (n) 
Cases   130 
Controls 130 
 
Table 1. Number of cases and controls 
 
PATIENT DEMOGRAPHICS 
Gender Distribution 
Out of the 260 subjects recruited for the study, there were 203 males and 57 females with 
a higher predominance of males in both the cases and control categories. There was a 
statistically significant difference between the cases and controls (OR 4.09 95% CI 2.10-
7.95 p value < 0.001) 
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                         Figure12. Number of males & females in Controls and Cases 
 
Amongst the females, majority of the cases and controls belonged to the overweight and 
obese categories. 
 
Figure 13. Number of males & females in different BMI groups 
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Age Distribution 
The mean age of the study population was 46 with a range from 18 to 80 (S.D of 11.93). 
Two – sample t test with equal variances showed : 
                                           
Table 2. Age Distribution between cases and controls 
 
 
Table 3. Age in different body mass index categories 
 
 
Mean age across all the BMI groups were similar. 
Group n Mean SE SD 95 % CI 
Controls 130 45.3 1.042773 11.89 43.24  -   47.36 
Cases 130 48.19 1.043371 11.90 46.13  -  50.26 
BMI n Mean SD Range 
18.5 – 24.9 54 46.02 13.92 18 - 80 
25 -29.9 101 47.96 11.50 24 - 77 
>= 30 101 46.24 11.21 22 - 70 
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Figure14. Mean Age in body mass index categories 
 
 
Stage of Chronic Venous Insufficiency 
Of the 130 controls, 79 had C2 disease, 50 had C3 disease and 56 had C4 disease. C0 and 
C1 were excluded from the study. The severity in each limb amongst the controls was 
similar as given in the following chart : 
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Mean Age
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Figure15.  Distribution of C stage in each limb of the Controls 
On comparing the Body Mass Index with the C stage within the controls, we found that 
there were similar number of obese patients in all the C categories, with more overweight 
subjects with C2 disease. 
 
Figure 16.  Distribution of body mass index in each C stage of the Controls 
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Of the 130 cases, 55 had C5 disease and 92 had C6 disease. As each patient can have 
more than one C stage, 37 of them had concomitant C2 disease, 33 had C3 disease and 58 
of the cases had C4 disease. Within the cases, the active ulcers were seen more on the left 
limb.  
 
Figure 17. Distribution of C stage in each limb of the Cases 
 
The number of patients with active ulcers in the overweight and obese category were 
more compared to the ones with healed ulcers. 
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Figure 18.  Distribution of body mass index in each C stage of the Cases 
Duration of Ulcer 
The mean duration of ulcer in those with C6 disease was 32.72 months, ranging from 1 
month to 360 months, with a Standard Deviation of 54.64. 
 
Figure 19. Duration of ulcer in patients with C6 disease 
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Recurrent Ulcers 
Amongst the cases, 72 patients (55.4%) had recurrent ulcers with a mean recurrence of 
4.08 ( Range  - 1 – 20 ) There were more recurrences in patients who were overweight or 
obese, however, it was not statistically significant. ( p value = 0.702) 
 
Figure 20.  Recurrence of ulcers in patients with C6 disease 
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Figure 21. Recurrence of ulcer in different BMI groups in patients with C6 disease 
 
Use of Compression Stockings 
150 out of 260 patients gave a history of not using compression stockings. This despite 
the fact that it is one of the first line of management for patients with chronic venous 
insufficiency. More number of cases gave a history of using compression stockings than 
controls. ( p value < 0.001) This probably, reflects the awareness amongst those with 
more severe disease.  
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Figure 22. Use of compression stockings in Controls and Cases 
 
BODY MASS INDEX 
The primary objective of the study was to find the association between Body Mass Index 
and venous ulcers.  
The mean height of the study population was 165 cm and mean weight was 79.5 kg. 
The Body Mass Index of the study population ranged from 17.60 to 53.50. Predominant 
part of the population belonged to the overweight and obese categories. The mean Body 
Mass Index was 29.04.  
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Figure 23.  Distribution of Cases and Controls according to Body Mass Index 
 
However, there was no statistically significant difference in the Body mass index between 
the two arms (OR 0.98, 95% CI 0.94 – 1.02). There was no statistically significant 
difference in both obesity (OR 0.57, 95% CI 0.29 – 0.34, p value 0.446) and overweight 
between the controls and cases (OR 0.6,7 95% CI 0.34 – 1.31). 
 n Mean SE SD 95 % CI 
Controls 130 29.34 0.44 5.07 28.46 – 30.22 
Cases 130 28.73 0.57 6.56 27.59 – 29.87 
 
 Table 4 . Body mass index in controls vs. cases 
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As the Body Mass Index classification proposed for the Asian population is different, we 
compared the two arms with the specified categories. However, there was no statistically 
significant difference between the controls and cases (p value = 0.263). 
 
Figure 23.  Distribution of Cases and Controls according to Body Mass Index – 
Asian Classification 
 
ANALYSIS OF OTHER RISK FACTORS 
Type of lifestyle 
The type of lifestyle was similar between the two groups, with predominant part of the 
study group amongst both the cases and controls leading a sedentary lifestyle. Only 10 
percent of the cases and 7.6 percent of the controls said that they exercise regularly. The 
cases who exercised regularly had an average Body Mass Index of 23.90. 
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Figure 24. Comparison of Type of lifestyle between controls and cases 
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History of use of oral contraceptive pills 
Only 8.7 percent of the females in the study population gave a history of use of oral 
contraceptive pills.  
Smoking 
There were 66 smokers in the study population. 42 out of the 130 cases smoked, whereas 
24 out of the 130 controls gave a history of smoking which was statistically significant 
between the two arms. ( p value = 0.010) ( OR 2.10, 95 % CI 1.19 – 3.75) 
However, on multivariate analysis, it was not found to be statistically significant between 
the cases and controls. (p value = 0.178) (OR 1.59, 95 % CI 0.81 – 3.16)  
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Figure 25. Smoking within Controls 
 
 
Figure 26. Smoking within Cases 
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Hours of Standing 
The mean number of hours of standing in the study population was 5.08 hours. Prolonged 
periods of standing was statistically significant between the controls and cases. (p value = 
0.034) Hence, it can be considered as one of the factors that have an association with 
ulceration in patients with venous disease. (OR 1.16, 95% CI 1.08 – 1.26)  
 
Figure 27. Comparison of the number of hours of standing between controls and cases 
 
History of Trauma to the limb 
Out of 130 cases, only 12 had a history of trauma to the right limb. Out of the 12, 10 of 
them had ulcers on the same limb. 7 cases gave a history of trauma to the left limb and all 
of them had ulcers on the same limb. 
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Limb Trauma n p value 
Right :  Control 
             Case 
6 
12 
130 
130 
0.143 
Left   :  Control 
             Case 
8 
7 
130 
130 
0.790 
 
Table 5 . History of trauma in controls vs. cases 
 
  
Family History  
Equal Number of cases and controls had a family history of venous disease. 
  
Figure 28. Comparison of family history of venous disease between controls and 
cases 
13
117
Controls
Yes No
13
117
Cases
Yes No
75 
 
 
Deep Vein Thrombosis 
7 cases and one control gave a history of deep vein thrombosis in the past in the right 
limb. 18 cases and 3 controls had a past history of deep vein thrombosis in the left limb. 
History of deep vein thrombosis was statistically significant in both the limbs. (p value < 
0.05) 
Limb History of Deep Vein 
Thrombosis 
n p value 
Right :  Control 
             Case 
1 
7 
130 
130 
0.031 
Left   :  Control 
             Case 
3 
18 
130 
130 
0.001 
 
Table 6. History of Deep Vein Thrombosis in controls vs. cases 
 
22 patients in the study population had chronic thrombosis on the Duplex, out of which 20 
were patients with active or healed ulcers. Amongst the cases, 60 percent belonged to the 
overweight category. 
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Figure 29.  Body mass index classification of all the cases and controls who had a 
chronic thrombus on Duplex 
We then took the patients who had chronic deep vein thrombosis either historically or on 
Duplex and found that it was statistically significant between the cases and controls. (OR 
10.08, 95% CI 2.96 – 34.31) (p value < 0.001)  
On multivariate analysis, it continued to be a statistically significant factor and hence, 
associated with ulceration in patients with venous disease. (OR 13.15, 95% CI 3.43 – 
50.31)  
 
0
0
3
0
12
1
5
1
0 2 4 6 8 10 12 14
Cases
Controls
Chronic thrombosis on Duplex
> = 30 25 - 29.9 18.5 - 24.9 < 18.5
77 
 
 
Comorbidities 
 
Comorbidities Cases Controls Pearson Chi2 p value 
Diabetes Mellitus 25 (19.23%) 23 (17.69%) 0.749 
Chronic Kidney Disease 2 (1.53%) 0 0.156 
Heart Disease 4 (3.07%) 6 (4.61%) 0.519 
 
Table 7. Comorbidities 
 
Venous Duplex Characteristics 
The following characteristics were compared on the Duplex : 
i. Deep Vein Thrombosis 
ii. Deep Venous Reflux in the Femoral Vein 
iii. Deep Venous Reflux in the Popliteal Vein 
iv. Saphenofemoral junction incompetence 
v. Saphenopopliteal junction incompetence 
vi. Perforator incompetence 
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The duplex characteristics were comparable between controls and cases. Perforator 
incompetence was the most common finding followed by saphenofemoral junction 
incompetence in both the controls and cases. 
 
Figure 30. Comparison of Duplex findings between controls and cases 
 
Right Limb 
 Controls 
 
Cases p value 
DVT 
 
 
1 (0.76%) 5 (3.84%) 0.079 
DVR Femoral Vein 
 
 
21 (16.5 %) 24 (18.46%) 0.392 
DVR Popliteal Vein 
 
14 (10.76%) 21 (16.15%) 0.108 
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SFJ Incompetence 
 
 
44 (33.84%) 40 (30.76%) 0.963 
SPJ Incompetence 
 
 
 
 
10 (7.69%) 10 (7.69%) 0.653 
Perforator Incompetence 
 
 
 
89 (68.46%) 84 (64.61%) 0.373 
 
          Table 7. Duplex Characteristics in the right limb - controls and cases 
 
Left Limb 
 Controls 
 
Cases p value 
DVT 
 
 
2 (1.53%) 1 (0.76%) <0.001 
DVR Femoral Vein 
 
 
30 (23.07 %) 33 (25.38%) 0.622 
DVR Popliteal Vein 
 
 
19 (14.61%) 31 (23.84%) 0.048 
SFJ Incompetence 
 
 
58 (44.61%) 49 (37.69%) 0.246 
SPJ Incompetence 
 
 
7 (5.38%) 18 (13.84%) 0.034 
Perforator Incompetence 
 
 
100 (76.92%) 104 (80%) 0.126 
 
         Table 8. Duplex Characteristics in the left limb - controls and cases 
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Figure 31. Comparison between Duplex findings in cases and body mass index 
categories 
 
Figure 32. Comparison between Duplex findings in cases and body mass index 
categories 
0 2
12
5
0
6
12
9
0
12
17 15
2
32
50
45
0
8 10 8
1
19
27 26
0
10
20
30
40
50
60
< 18.5 18.5 - 24.9 25 - 29.9 > = 30
Cases
DVT DVR FEM DVR POP PERF INCOMP SPJ INCOMP SFJ INCOMP
0 0 1 10 1
14
10
1
3
11
8
2
19
50
52
1 2
7
4
1
16
26
30
0
10
20
30
40
50
60
< 18.5 18.5 - 24.9 25 - 29.9 > = 30
Controls
DVT DVR FEM DVR POP PERF INCOMP SPT INCOMP SFJ INCOMP
81 
 
MULTIVARIATE ANALYSIS 
Using the factors that were found to be significant, a multivariate analysis was done. 
Variables  
 
OR(95% CI) 
 
p-value 
 
 
Age 
 
1.03(1.01,1.06) 
 
0.007 
 
Deep Vein 
Thrombosis 
 
No 
ref 
 
<0.001 
 
Yes 
 
 
13.16(3.44,50.31) 
 
Gender 
 
Female 
 
 
Ref 
 
 
 
 
<0.001 
 
Male 
 
 
3.27(1.49,7.18) 
 
 
Body Mass Index 
 
1.02(0.97,1.07) 
 
0.4 
 
 
Smoking 
 
 
No 
 
 
Ref 
 
0.18 
 
Yes 
 
 
1.6(0.81,3.16) 
 
Deep Venous 
Reflux in the 
Popliteal Vein 
 
 
No 
 
Ref 
 
0.11 
 
 
Yes 
 
1.75(0.88,3.48) 
 
Saphenofemoral 
junction 
Incompetence 
 
 
 
No 
 
Ref 
  
 
Yes 
 
2.66(0.95,7.45) 
 
0.06 
 
 1.64(0.77,3.51) 0.2 
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Not formed 
 
  
 
Prolonged Standing 
 
1.16(1.08,1.26) 
 
<0.001 
 
 
Table 9. Multivariate Analysis 
 
The model fit was good (p-value=0.48, Hosmer-lemshow fit statistics) and the variables 
included in the model have an r-square of 0.1998 (Mcfadden’s)  
 Hence, the following were found to be statistically associated with venous ulceration: 
Older age, male gender, Deep Vein Thrombosis and prolonged periods of standing. 
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DISCUSSION 
Chronic venous insufficiency is the most common venous disorder that is seen in the 
Vascular surgery out-patient clinic at our institution. Venous ulcers are slow to heal and 
are prone to recur. Hence, they are associated with high morbidity and a huge 
socioeconomic burden to the patient and society. There is an increasing trend in 
incidence of obesity worldwide, including India. There is a strong association between 
obesity and non communicable diseases.  
 
It is in this context that we undertook this study with an aim to elucidate the association 
between increasing body mass index and ulceration in patient with venous 
insufficiency.  We also analyzed other risk factors that might lead to progression of 
disease to ulceration, with the help of a structured questionnaire.  
We had 130 cases with an active or healed ulcer and 130 controls with no ulcers but 
with documented venous insufficiency. Most of our patient population was middle aged 
with a mean age of 46.7 years. We had more males than females. Even though 
classically varicose veins have been described to be more common in females, only  
21.9 % of our study population were females. We found a significant association 
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between the male gender and ulceration in venous disease.  
 
38.8% of the 260 patients recruited were obese and another 38.8 % were overweight.  
45.5% of the obese patients had an active or healed ulcer.  It was evident that most of the 
patients with venous insufficiency were either overweight or obese. However, there was 
no statistically significant difference between those with ulcers and those with no 
ulcers as far as body mass index was concerned. 
Prior studies have shown as association between obesity and advanced stages of venous 
Disease. However, most of them have shown an association in females but not in males.  
The criteria to recruit the patients for our study was to have a documented venous 
insufficiency on a venous Doppler. Studies by Padberg et al and the Bonn Vein study 
showed that there might no anatomic evidence of venous insufficiency in the obese, 
suggesting that probably the etiology in them is different. 
. 
Our secondary objective was also to look at other etiological factors that are associated 
with advanced stages of the disease. We analyzed factors like age, gender, recurrent 
ulcerations, numbers of hours of standing, history of trauma to the limb, history of deep 
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vein thrombosis, type of lifestyle, smoking, comorbidities, usage of compression 
stockings, family history of venous disease and usage of oral contraceptive pills.  
55.4% of the cases had recurrent ulcers with a mean recurrence of 4.08. This highlights 
the huge morbidity that is associated with venous ulcers. Recurrent ulcers would mean 
more visits to the hospital, more number of loss of days at work and an overall increased 
socio-economic burden for the patient. 77.8 % of the patients with recurrent ulcers were 
either overweight or obese.  
 
Our data reflected that only 41.9 % of our study population had used compression 
stockings. This despite the fact that compression is the mainstay of treatment for venous 
insufficiency. Only 10 % of the patients gave a history of exercing regularly while a 
predominant part of them led a sedentary life. 32.30% of the cases were smokers and it 
was a statistically significant factor between the two arms of the study. 
Probably more awareness needs to be created amongst our patients regarding lifestyle 
changes and compliance to compression stockings for the treatment of venous disease. 
The mean number of hours of standing in the study population was 5.08 hours. 
Prolonged periods of standing was statistically significant between the controls and 
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cases. As shown in most studies, in our study too we found that deep vein thrombosis 
was significantly associated with venous ulcers. We also compared the duplex 
characteristics between the cases and controls and found them to be similar between the 
two groups and similar across all body mass index categories.  
 
Finally, on multivariate analysis we found - older age, male gender, deep vein thrombosis 
and prolonged periods of standing, to have a significant association with ulceration in 
venous disease. 
 
LIMITATIONS 
We made every effort to try and reduce selection bias by trying to recruit contiguous 
patients.  
We did have the component of recall bias as our data on the etiological factors was based 
on the history given to us by the patients. 
As our patients were recruited from the out-patient clinic our data might not be 
representative of the entire population but only of those who presented to the hospital. 
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CONCLUSIONS 
 
There was no association between body mass index and ulceration in patients with venous 
disease. 
Older age, male gender, deep vein thrombosis and periods of prolonged standing were 
associated with venous ulceration. 
However, the investigators did consider the possibility of a different pathophysiology of 
venous disease in the obese and hence, venous duplex alone might not be an adequate 
diagnostic tool to select obese patients for future studies. We propose that further studies 
need to be done in this regard and follow up the obese patients in the control arm to see if 
they develop ulcers in the future. It is only then that we will be able to establish obesity as 
risk factor. 
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ANNEXURES 
ANNEXURE 1  - PATIENT INFORMATION AND CONSENT FORM 
CHRISTIAN MEDICAL COLLEGE, VELLORE 
DEPARTMENT OF GENERAL SURGERY AND VASCULAR SURGERY 
 
PATIENT INFORMATION SHEET  
 
You are being invited to participate in a study to see the influence of body mass index in 
developing ulceration in patients with venous disease. Thank you for agreeing to be part 
of this study.  
 
What is the background behind this study?  
Chronic venous disease refers to abnormalities of veins which leads to skin changes and 
ulcers. Venous ulcers are the most common cause of ulcers. They are difficult to heal and 
tend to come back even after they have healed.  Hence, it is important to study the factors 
which can cause or worsen this disease. 
 
What is the purpose of the study? 
The purpose of this study is to look at if overweight is a risk factor for developing 
ulceration in venous disease. 
 Answering this question will help us target lifestyle changes to help prevent progression 
of disease. 
 
If you take part what will you have to do? 
If you agree to participate in this study, you will be asked a few questions about your 
disease. You will be examined by the doctor and the findings will be noted. Your height 
and weight will be measured. You will not be asked to undergo any invasive procedure or 
blood test as part of the study. 
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Can you withdraw from this study after it starts?  
Your participation in this study is entirely voluntary and you are also free to decide to 
withdraw permission to participate in this study. Your refusal or withdrawal will not 
affect the standard of care you would receive at our institution's health services. 
 
What will happen if you develop any study related injury?  
We do not expect any untoward event to occur due to the study as there is no intervention 
required.  
 
Will your personal details be kept confidential?  
The results of this study will be published in a medical journal but you will not be 
identified by name in any publication or presentation of results.  
 
If you have any further questions, please contact 
- Dr. Pearl Lal, Department Of General Surgery, Christian Medical College, Vellore 632004, 
Telephone: +9104162282079 or email:lalpearl@gmail.com 
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Informed Consent 
 
Study Title: Influence of body mass Index on developing ulceration in patients with venous 
disease  
 
Study Number: ____________ 
 
 
Subject’s Name: _________________________________________ 
 
 
Date of Birth / Age: ___________________________ 
 
 
 
(i)  I confirm that I have read and understood the information sheet dated 
____________ for the above study and have had the opportunity to ask questions.[  
] 
 
(ii)  I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical care or legal 
rights being affected.       [  ] 
 
(iii)  I agree not to restrict the use of any data or results that arise from this study provided 
such a use is only for scientific purpose(s). [  ] 
 
(iv)  I agree to take part in the above study. [  ] 
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Signature (or Thumb impression) of the Subject 
 
Date: _____/_____/______ 
 
Signatory’s Name: _________________________________          
 
OR 
 
Representative: _________________ 
 
Date: _____/_____/______ 
 
 
Signature of the Investigator: ________________________ 
 
Date: _____/_____/______ 
 
Study Investigator’s Name: _________________________ 
 
 
Signature or thumb impression of the Witness: ___________________________ 
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Date: _____/_____/_______ 
 
Name & Address of the Witness: ______________________________ 
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ANNEXURE 2 – CLINICAL RESEARCH FORM 
 
PROFORMA 
Study Title: Influence of body mass Index on developing ulceration in patients with venous 
disease  
CASE              ⃝  Serial Number  : 
CONTROL     ⃝  Serial Number  : 
 
1. Name  :  
2. Hospital number  :  
3. Contact Number  : 
4. Age  : 
5. Gender : Male       ⃝   Female       ⃝ 
 
6. Duration of ulcer  :__________ months 
 
7. Past history of trauma to the limb      : Right -   Y     ⃝        N        ⃝ 
Left   -   Y     ⃝        N        ⃝ 
8. Past history of Deep Vein Thrombosis     :Right -   Y     ⃝        N        ⃝ 
                                                                              Left   -      Y     ⃝        N        ⃝ 
9. Past history of ulcer                                 : Right -   Y    ⃝        N        ⃝ 
                                                                     Left   -   Y     ⃝        N        ⃝ 
      If Yes, Number of recurrences                        : 
10. Number of hours of standing per day         : 
11. Type of lifestyle                                            :   a. Sedentary 
                                                                           b. Moderate Activity 
                                                                           c. Exercise regularly 
 
                   
12. Smoking                               :       Y     ⃝        N        ⃝ 
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13. Have you used compression stockings          :       Y     ⃝        N        ⃝ 
 
14. Family history of venous disease                :       Y     ⃝        N        ⃝ 
 
 
15. Diabetes Mellitus                            :       Y     ⃝        N        ⃝ 
16. Hypertension                    :       Y     ⃝        N        ⃝ 
17. Chronic Kidney Disease                :       Y     ⃝        N        ⃝ 
18. Heart disease                            :       Y     ⃝        N        ⃝ 
 
19. If female, history of OCP use                : Y    ⃝        N        ⃝ 
 
 
20. Height     :     __________ (in cm) 
21. Weight     :     __________ (in kg) 
22. BMI               :  
 
23. C  STAGE              :  Right limb  -  
                             Left limb   - 
 
24. Peripheral pulses             :    Y     ⃝        N        ⃝ 
25.  ABPI                                               :  Right limb - 
                                                            Left limb -  
 
26. Venous Duplex Findings  : 
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ANNEXURE 3 – IRB APPROVAL  
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ANNEXURE 4 – FUND APPROVAL 
 
105 
 
ANNEXURE 5 – STROBE GUIDELINES 
STROBE Statement—Checklist of items that should be included in reports of case-control 
studies  
 
Item 
No Recommendation 
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the 
abstract 
(b) Provide in the abstract an informative and balanced summary of what was 
done and what was found 
Introduction 
Background/rationale 2 Explain the scientific background and rationale for the investigation being 
reported 
Objectives 3 State specific objectives, including any prespecified hypotheses 
Methods 
Study design 4 Present key elements of study design early in the paper 
Setting 5 Describe the setting, locations, and relevant dates, including periods of 
recruitment, exposure, follow-up, and data collection 
Participants 6 (a) Give the eligibility criteria, and the sources and methods of case ascertainment 
and control selection. Give the rationale for the choice of cases and controls 
(b) For matched studies, give matching criteria and the number of controls per 
case 
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and 
effect modifiers. Give diagnostic criteria, if applicable 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and details of methods of 
assessment (measurement). Describe comparability of assessment methods if 
there is more than one group 
Bias 9 Describe any efforts to address potential sources of bias 
Study size 10 Explain how the study size was arrived at 
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If applicable, 
describe which groupings were chosen and why 
Statistical methods 12 (a) Describe all statistical methods, including those used to control for 
confounding 
(b) Describe any methods used to examine subgroups and interactions 
(c) Explain how missing data were addressed 
(d) If applicable, explain how matching of cases and controls was addressed 
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(e) Describe any sensitivity analyses 
Results 
Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers potentially 
eligible, examined for eligibility, confirmed eligible, included in the study, completing 
follow-up, and analysed 
(b) Give reasons for non-participation at each stage 
(c) Consider use of a flow diagram 
Descriptive data 14* (a) Give characteristics of study participants (eg demographic, clinical, social) and 
information on exposures and potential confounders 
(b) Indicate number of participants with missing data for each variable of interest 
Outcome data 15* Report numbers in each exposure category, or summary measures of exposure 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and 
their precision (eg, 95% confidence interval). Make clear which confounders were 
adjusted for and why they were included 
(b) Report category boundaries when continuous variables were categorized 
(c) If relevant, consider translating estimates of relative risk into absolute risk for a 
meaningful time period 
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and sensitivity 
analyses 
 
Discussion 
Key results 18 Summarise key results with reference to study objectives 
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or 
imprecision. Discuss both direction and magnitude of any potential bias 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, 
multiplicity of analyses, results from similar studies, and other relevant evidence 
Generalisability 21 Discuss the generalisability (external validity) of the study results 
Other information 
Funding 22 Give the source of funding and the role of the funders for the present study and, if 
applicable, for the original study on which the present article is based 
 
*Give information separately for cases and controls. 
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ANNEXURE 6   - DATA SET 
slno caseslno contslno 
 
name hospno phno age gender durulcer traumart traumalt veinrt veinlt ulcerrt ulcerlt recurr standing lifestyle 
1 1  
 
MITHU DEBNATH 244904F  43 1 12 2 2 2 2 1 2 10 3 2 
2 2  
 
C S PAPA NADAM 776367G  80 1 144 2 2 2 2 1 1 3 3 1 
3 3  
 
SWAPAN PAUL 779526G  62 1 2 2 2 2 2 2 2 0 5 2 
4 4  
 
SUDIP MONDAL 659860G  61 1 1 2 2 2 2 1 2 1 12 1 
5 5  
 
MD ANISUR RAHMAN 
TALUKDAR 792966G  45 1 12 2 2 2 1 2 1 2 12 2 
6 6  
 
MOGILAMMA 172072D  58 2 36 1 2 2 2 2 2 0 2 1 
7 7  
 
MD ABDUL KASEM 390750F  42 1 120 2 2 2 2 2 1 6 6 1 
8 8  
 
BHASKAR REDDY M 456177F  44 1 36 2 2 2 2 1 1 5 2 1 
9 9  
 
VIJAYA KUMAR A 946717F  25 1  2 2 2 2 2 1 0 16 2 
10 10  
 
KISHOR MODI 800824G  36 1  1 2 2 2 1 2 0 10 2 
11 11  
 
MUNIRATHINAM 726722G  31 1  2 2 2 2 1  4 3 2 
12 12  
 
SHAON DUTTA 780165G  57 2 5 2 2 2 2 2 1 1 2 1 
13 13  
 
RAO M N 580096C  52 1 8 2 2 1 1 2 2 0 3 1 
14 14  
 
NAIDU N M 222749F  51 1 10 2 2 1 2 1 2 2 4 1 
15 15  
 
BHUPEN BAISHYA 293428G  50 1 24 2 2 2 2 2 2 0 12 2 
16 16  
 
JEYARAJ ERNEST 643784D  35 1 24 2 2 2 2 1 1 2 0 1 
17 17  
 
MADHU D 738068D  31 1 3 2 2 2 2 1 2 5 10 1 
18 18  
 
AJAY KRISHNA PAUL 820313G  42 1  2 2 2 2 1 2 6 14 1 
19 19  
 
ANURAJ RANA 835767G  33 1 12 2 2 2 2 2 2 0 4 1 
20 20  
 
SAROAR AHMED 862661F  34 1 36 2 2 2 1 2 1 2 7 1 
21 21  
 
MD EKBAL MOLLA 756678G  34 1 12 2 2 2 2 2 2 0 5 1 
22 22  
 
RAJARAN SHAW 132412G  52 1 12 2 2 2 2 2 1 2 10 1 
23 23  
 
MITRA ANANDA 
GOPAL 785122G  49 1  2 2 2 2 1 2 1 10 1 
24 24  
 
SANJAY KUMAR 
ROOF 794474G  42 1 15 2 2 2 2 2 2 0 9 3 
25 25  
 
MOST JERINA 
AKHTAR 737816G  61 2 84 2 2 2 2 2 2 0 1 1 
26 26  
 
DHANASEKARAN N 778779C  52 1 120 2 2 2 1 2 1 1 1 2 
27 27  
 
KUMARA VENKATA 
RAMANAIAH 823752G  49 1  2 2 2 1 2 2 0 12 1 
28 28  
 
INDRANI 524618C  52 2  2 2 1 1 1 1 3 2 1 
29 29  
 
PRASAD D V S 627001F  52 1 120 2 2 2 2 2 1 4 3 1 
30 30  
 
MOORTHY R 232340A  65 1 84 2 2 2 2 2 1 2 10 2 
31 31  
 
ORCANA RANI DEB 411528G  49 2 12 2 2 2 2 2 1 2 6 1 
32 32  
 
HARILAL 453648G  44 1  2 2 2 2 2 2 0 9 1 
33 33  
 
SUBRAMANI C 266091C  47 1 6 2 2 2 2 2 1 2 4 2 
34 34  
 
PRADEEP KUMAR 
SHRMA 831308G  32 1  2 2 2 2 1 2 0 14 1 
35 35  
 
RADHA 348629A  47 2 12 2 2 2 2 2 1 6 10 2 
36 36  
 
KHILU RAM 
BANJARE 699072G  43 1 1 2 2 2 1 2 1 2 12 2 
37 37  
 
MOHAMMED IQBAL 491027G  37 1 7 2 2 2 1 2 1 2 9 2 
38 38  
 
DORASWAMY 
REDDY T 273958G  62 1 36 2 2 2 2 1 2 0 3 1 
39 39  
 
SOLOMOM 778035C  35 1 12 2 2 2 2 2 1 2 5 1 
40 40  
 
REJAUL KHAN 809330G  30 1  2 2 2 2 2 1 0 9 2 
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41 41  
 
GOPALAKRISHNAN T 364466F  28 1 6 2 2 2 1 2 2 0 4 1 
42 42  
 
KHALILUR RAHMAN 601004G  46 1 2 2 2 2 2 1 1 3 3 1 
43 43  
 
SELVAKUMAR M 467574G  54 1 6 2 2 2 2 1 2 2 3 1 
44 44  
 
APURBA SARKAR 052040F  54 1  2 2 2 2 1 1 8 10 2 
45 45  
 
GUDI REDDY 
PRAKASH 788416G  33 1 9 2 1 2 2 2 2 0 4 1 
46 46  
 
SATHEESH S 409476F  22 1  2 1 2 2 2 1 1 8 2 
47 47  
 
MOORTHY 796445G  53 1 180 2 2 2 2 1 2 1 8 1 
48 48  
 
SATYACHARAN DAS 201604G  65 1 72 1 2 2 2 1 2 7 8 2 
49 49  
 
AMBIKA A 032470F  62 2  2 2 2 2 1 1 0 3 2 
50 50  
 
BHAGYARAJU N 289762G  28 1  2 2 2 2 2 1 0 3 1 
51 51  
 
DEONANDAN RAM 732419G  42 1  1 1 2 2 1 2 5 4 2 
52 52  
 
MARKONDAIAH 723293D  74 1 360 2 2 2 2 2 2 0 10 3 
53 53  
 
BHANU SHARMA 757367G  43 1 5 2 2 2 1 2 2 0 3 1 
54 54  
 
TAPAN KUMAR SAHA 765356G  55 1 240 1 2 1 2 2 2 0 14 1 
55 55  
 
MARUTHAIYAN M 688310G  58 1  2 2 2 2 2 1 0 10 3 
56 56  
 
ASHOK NAYAK 441655G  39 1 48 2 2 2 2 2 1 15 9 1 
57 57  
 
RAVICHANDRAN 638602B  53 1  2 2 2 1 2 1 0 2 3 
58 58  
 
SUJOY KUMAR 
MONDAL 685231G  65 1  2 2 2 1 2 1 0 1 1 
59 59  
 
TAPPA MEENA 494943G  60 2  2 2 2 2 1 2 0 1 1 
60 60  
 
MOHIT CHAWDA M 749733G  48 1 24 2 2 2 2 2 2 0 6 1 
61 61  
 
SABITRI DUTTA 954588B  65 2 48 2 2 2 2 2 1 6 1 1 
62 62  
 
VIJAYABASKAR 
REDDY 691585G  57 1 14 1 2 1 1 2 2 0 2 1 
63 63  
 
DURAISAMY G 719756G  48 1  2 2 2 2 1 2 0 8 2 
64 64  
 
PUNNIYAVATHI G 865340F  58 2 24 2 2 2 2 1 2 5 3 2 
65 65  
 
ALAKESH 
CHATTERJEE 746809G  28 1 2 2 2 2 2 2 2 0 10 1 
66 66  
 
DHANASEKARAN 778779C  52 1 6 2 1 2 1 2 1 10 4 2 
67 67  
 
MANOGARAN 592690D  56 1 24 2 2 2 2 2 2 0 12 3 
68 68  
 
SURAJIT DEY 190933D  57 1 1 2 1 2 2 2 2 0 5 3 
69 69  
 
NEELAKANTAN 519314F  42 1 3 2 2 2 2 2 1 3 10 3 
70 70  
 
SURESH SAH G 743350G  32 1 3 2 2 2 2 2 2 0   
71 71  
 
NAMADEVALU 
REDDY 701375D  77 1 72 2 2 2 1 1 2 0 2 3 
72 72  
 
TULASI RAMAN 421080C  48 1 6 2 2 2 2 2 2 0 1 1 
73 73  
 
JOYRAJ SHIL 445558G  42 1  2 2 2 2 1 2 0 1 1 
74 74  
 
MANIKAM L 543962D  62 1 60 2 2 2 2 2 1 1 11 1 
75 75  
 
V SATHISH 391860G  36 1  2 2 2 2 2 1 10 2 1 
76 76  
 
SUNIL PRASAD KANU 430826G  44 1  2 2 2 2 1 1 6 8 1 
77 77  
 
SUNIL AGRAWAL 749249G  53 1 6 2 2 2 2 1 2 2 1 1 
78 78  
 
RADHA RANI BISWAS 494780G  59 2 1 2 2 2 2 2 2 0 10 2 
79 79  
 
PANDIYAN P 682240G  48 1 3 2 2 2 2 2 1 3 1 1 
80 80  
 
SARJU MODI 412651G  65 1 96 2 2 2 2 2 2 0 15 1 
81 81  
 
AMARAVATHI 506325C  34 2 12 2 2 2 2 1 2 2 1 1 
82 82  
 
MD SAHABUL ALAM 408409G  43 1 3 2 2 2 2 2 2 0 2 1 
83 83  
 
MOHMMED ALI 407258G  51 1 6 2 2 1 2 1 2 2 1 1 
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84 84  
 
SENTHIL KUMAR 619226F  42 1  2 2 2 2 1 1 0 2 1 
85 85  
 
MOHAMMAD 
SAHABUL ALAM 408409G  43 1 3 2 2 2 2 2 2 0 1 1 
86 86  
 
SANSAMMA M 806294F  44 2  2 2 2 1 2 1 0 2 1 
87 87  
 
SUNNY 414878G  43 1 6 2 2 2 2 2 1 4 7 2 
88 88  
 
JAMES BAKTHAN 727327D  30 1 2 2 2 2 2 2 1 3 4 2 
89 89  
 
RABINDRA NATH 
MAITI 408802G  59 1  2 2 2 1 2 1 0 2 1 
90 90  
 
DILIP BARUA 369464D  61 1 144 2 2 2 2 1 2 3 3 2 
91 91  
 
IBRAHIM KHALEEL 
SHARIFF 600325G  35 1  2 2 2 2 1 2 3 12 1 
92 92  
 
SRI RAM J 152633G  38 1  2 2 2 2 1 2 2 8 1 
93 93  
 
CHINNAYERRAIAH 
CHETTY G 470436G  56 1 24 2 2 2 2 2 2 0 10 2 
94 94  
 
NARAYANA M 457736G  45 1 24 1 2 2 2 2 1 3 4 1 
95 95  
 
J LENIN BABU 396123G  34 1 36 2 1 2 2 2 1 3 5 1 
96 96  
 
VELU 789538F  48 1 1 2 2 2 2 1 2 4 9 3 
97 97  
 
DURAIRAJ JOSEPH K 056329G  61 1  2 2 2 2 1 1 0 5 1 
98 98  
 
SATISH 
CHOITHRAMANI 480503G  58 1 2 2 2 2 2 1 2 1 6 1 
99 99  
 
GOUR HARI BERA 714264G  61 1 3 1 2 2 2 2 2 0 10 3 
100 100  
 
DHANASEKARAN P 105978G  29 1  1 2 2 2 1 2 2 8 2 
101 101  
 
SIVAKUMAR A 705045G  42 1 3 2 2 2 2 1 2 0 8 3 
102 102  
 
SIVASANKARAN R 482624G  51 1  2 2 2 2 1 2 0 8 2 
103 103  
 
VIRENDRA KR SINGH 661555G  64 1 24 2 2 2 2 1 1 20 10 1 
104 104  
 
SANKAR DAS 787696G  49 1 2 1 1 2 2 2 1 3 5 2 
105 105  
 
SOLOMON RAJ 706184F  18 1 36 2 2 2 2 2 2 0 6 3 
106 106  
 
ARUN KUMAR 685616G  44 1 3 2 2 2 2 2 1 5 12 1 
107 107  
 
MALIGA R 536891G  56 1 12 1 2 2 2 1 2 3 3 1 
108 108  
 
DHIREN TAMANG 741723G  47 1 24 2 2 2 2 1 2 1 15 2 
109 109  
 
BASKARAN K 743172G  54 1 3 2 2 1 2 1 2 1 12 2 
110 110  
 
ARJUN PRASAD 809793F  41 1 96 2 2 2 2 2 1 6 1 1 
111 111  
 
PEYYALA JOHNSON 
KRUPAVARAM 716790G  48 1  2 2 2 2 1 1 0 1 1 
112 112  
 
SAMIRAN PRAMANIK 257801F  36 1 3 2 2 2 2 2 1 20 8 2 
113 113  
 
TULASI RAMAN 421080C  48 1 7 2 2 2 2 2 1 1 5 1 
114 114  
 
DINESH KUMAR 
KESHRI 140202B  48 1 60 2 2 2 2 2 1 10 1 1 
115 115  
 
DHANALAKSHMI 744432G  53 1  2 2 2 1 2 1 0 2 2 
116 116  
 
MURUGAN J 649297G  38 1 24 2 2 2 2 1 1 4 4 2 
117 117  
 
MURUGESAN K 833320G  65 1  2 2 2 2 1 2 0 6 1 
118 118  
 
NARAYANASWAMY 867861G  48 1  2 2 2 2 2 1 0 4 1 
119 119  
 
MUNUSAMY A 429572G  48 1 4 2 2 2 2 2 2 0 1 1 
120 120  
 
SURVA 
BHATTACHARYA 756712B  59 2 24 2 2 2 2 2 2 0 1 1 
121 121  
 
KUMAR 213635F  58 1 6 2 2 2 2 2 1 5 3 2 
122 122  
 
TARAKNATH 
KARMARKAR 5167579  35 1 2 2 2 2 2 2 1 3 7 2 
123 123  
 
IBRAHIM MD 019864G  35 1  2 2 2 2 1 1 2 5 1 
124 124  
 
RAJARAN SHAW 132412G  52 1 12 2 2 2 2 1 1 2 10 2 
125 125  
 
RAM GOPAL MOHTA 732300G  71 1 36 2 2 2 2 1 2 7 3 1 
126 126  
 
SHEIKH REZUL 
HOQUE 781729G  60 1 2 2 2 2 2 2 2 0 3 1 
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127 127  
 
MANI S 268836A  49 1 60 1 2 2 2 2 2 1 12 3 
128 128  
 
SIVAMANI M 071666D  64 1 6 2 2 2 2 1 2 3 10 1 
129 129  
 
SUNIL PRASAD KANU 430826G  44 1  2 2 2 2 1 1 0 12 1 
130 130  
 
GOPAL CHANDRA 
BANIK 408282G  68 1 18 2 2 2 2 2 2 0 5 1 
131  1 
 
REKHA C 587589C  39 2  2 2 2 2 2 2 0 1 3 
132  2 
 
MAGESHWARI 679661F  27 2  2 2 2 2 2 2 0 5 2 
133  3 
 
GOUTAM 
CHATTERJEE 782066G  54 1  2 2 2 2 2 2 0 3 1 
134  4 
 
SUDHAKAR 243371G  41 1  2 2 2 2 2 2 0 4 2 
135  5 
 
CHANDANESHWAR 
MISHRA 447281G  28 1  2 2 2 2 2 2 0 2 1 
136  6 
 
BALAJI 545061G  24 1  2 2 2 2 2 2 0 8 2 
137  7 
 
SAIKET HALDER 766360G  32 1  1 1 2 2 2 2 0 8 1 
138  8 
 
DHANALAKSHMI 809265G  28 2  2 2 1 1 2 2 0 9 2 
139  9 
 
SAMRAT 
MUKHERJEE 405842G  45 1  2 2 2 2 2 2 0 5 1 
140  10 
 
AMBIGA R 858799G  24 2  2 2 2 2 2 2 0 2 2 
141  11 
 
SASI KUMAR 637146D  38 1  2 2 2 2 2 2 0 12 1 
142  12 
 
RAMPARWESH 
CHOUDHARY 742232G  41 1  2 2 2 2 2 2 0 2 1 
143  13 
 
BABUL CHANDRA 
NATH 407946G  58 1  2 2 2 2 2 2 0 1 1 
144  14 
 
PRATIK ROY 777017G  27 1  2 2 2 2 2 2 0 3 1 
145  15 
 
V DEVASAHAYAM 787109G  58 1  2 2 2 2 2 2 0 6 2 
146  16 
 
PRAKASH M K 648891F  40 1  2 1 2 2 2 2 0 6 3 
147  17 
 
NITHIYANANDAM D 816819C  49 1  2 2 2 2 1 2 0 6 1 
148  18 
 
SUMATHI K 270227G  31 2  2 2 2 2 2 2 0 8 1 
149  19 
 
BALARAMAN A 618078G  34 1  2 2 2 2 2 2 0 3 1 
150  20 
 
MARIAM BANU 844840G  28 2  2 2 2 2 2 2 0 10 2 
151  21 
 
GOVINDAYA D 521238F  36 1  2 2 2 2 2 2 0 12 2 
152  22 
 
KUMARAN A 600801G  46 1  2 2 2 2 2 2 0 13 2 
153  23 
 
AGILA 947660F  61 2  2 2 2 2 2 2 0 4 1 
154  24 
 
DAKSHIRAJU 
VENKATA SUBAMMA 606973G  53 2  2 2 2 2 2 2 0 5 1 
155  25 
 
S R GURUSWAMY 458105B  66 1  2 2 2 2 2 2 0 2 1 
156  26 
 
DHANALAKSHMI 413139G  53 2  2 2 2 2 2 2 0 3 1 
157  27 
 
PALTU HAZRA 083749F  30 1  1 1 2 2 2 2 0 8 2 
158  28 
 
DAKSHINAMOORTHY 797845G  39 1  2 2 2 2 2 2 0 4 1 
159  29 
 
BASKARAN 438884D  42 1  2 2 2 2 2 2 0 7 2 
160  30 
 
SAM CHRISTOPHER G 
A 117812A  68 1  2 2 2 2 2 2 0 1 1 
161  31 
 
SUBHASHINI 
TENNYSON 893565B  39 1  2 2 2 2 2 2 0 3 2 
162  32 
 
R K PRASAD 399923G  47 1  2 2 2 2 2 2 0 3 2 
163  33 
 
MANJULA 593308C  45 2  2 2 2 2 2 2 0 2 1 
164  34 
 
SELVAKUMAR C 432200G  33 1  2 2 2 2 2 2 0 6 2 
165  35 
 
AJITT KUMAR DEY 414531G  50 1  2 2 2 2 2 2 0 3 2 
166  36 
 
SARAVANA 
MOORTHY J 801059B  36 1  1 1 2 2 2 2 0 2 1 
167  37 
 
CLAMENSHIA 
SHANTHAKUMARI 064165A  52 2  2 2 2 2 2 2 0 1 1 
168  38 
 
MONOARA BEGUM 713664G  39 2  2 2 2 2 2 2 0 3 1 
169  39 
 THUMMALAPATI 
VENKATARAMANA 
BABU 800340G  37 1  2 2 2 2 2 2 0 12 1 
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170  40 
 
SAMRAT 
MUKHERJEE 405842G  45 1  2 2 2 2 2 2 0 2 1 
171  41 
 
KARTEEK SATTARU 416203G  30 1  2 2 2 1 2 2 0 1 1 
172  42 
 
VEERAMANI 765927G  34 1  2 2 2 2 2 2 0 8 2 
173  43 
 
SATHIYAMOORTHY 
Y 980133D  41 1  2 2 2 2 2 2 0 6 2 
174  44 
 
VIJAYA KUMAR E 691361G  52 1  2 2 2 2 2 2 0 2 1 
175  45 
 
GITA SUBBA 766506G  30 2  2 2 2 2 2 2 0 4 1 
176  46 
 
SALU GEORGE V P 344197G  49 2  2 2 2 2 2 2 0 2 1 
177  47 
 
CHALAPATTI 
ANKIPALLI 757786G  40 1  2 2 2 2 1 2 0 1 1 
178  48 
 
MANOJ GHANTY 400034G  43 1  2 2 2 2 2 2 0 1 1 
179  49 
 
KABITA ROY 344730G  43 2  2 2 2 2 2 2 0 4 1 
180  50 
 
YOBU IMMANUEL 166722C  40 1  2 2 2 2 2 2 0 3 1 
181  51 
 
CHINMAYEE 
TRIPATHY 746025G  44 2  2 2 2 2 2 2 0 1 1 
182  52 
 
MARIAMMA JOSEPH 782831G  71 2  2 2 2 2 2 2 0 2 1 
183  53 
 
SARAVANAN R 130545F  35 1  2 2 2 2 2 2 0 10 2 
184  54 
 
ASIT KUMAR PAL 755941G  61 1  2 2 2 2 2 2 0 3 2 
185  55 
 
JOHN BABU N 425100G  59 1  1 2 2 2 2 2 0 3 3 
186  56 
 
MOORTHI S 510559G  57 1  2 2 2 2 2 2 0 10 3 
187  57 
 
MAYANDI G 760651G  55 1  2 2 2 2 2 2 0 4 2 
188  58 
 
NEHA KUMARI 718329G  28 2  2 2 2 2 2 2 0 6 2 
189  59 
 
RAJENDRAN K 923691F  61 1  2 2 2 2 2 2 0 12 1 
190  60 
 
GIRIDHARA REDDY V 
J 869334F  46 1  2 2 2 2 2 2 0 12 1 
191  61 
 
ESWARA REDDY 
BOGALA 756428G  63 1  2 2 2 2 2 2 0 2 1 
192  62 
 
RAJESH E 693052G  34 1  2 1 2 2 2 2 0 6 3 
193  63 
 
GUDI GURU PRASAD 764979G  29 1  2 2 2 2 2 2 0 5 3 
194  64 
 
GHANA KANTA 
PHUKAN 476005G  66 1  2 2 2 2 2 2 0 1 1 
195  65 
 
MUKUL SHAW 723688G  42 1  2 2 2 2 2 2 0 2 1 
196  66 
 
BISWANATH DEY 753666G  69 1  2 2 2 2 2 1 0 4 1 
197  67 
 
KALAIRASI K 765201G  47 2  2 2 2 2 2 2 0 8 2 
198  68 
 
CHANDANESHWAR 
MISHRA 447281G  28 1  2 2 2 2 2 2 0 1 1 
199 0 69 
 
SAROJ DEVI 744967G  51 2  2 2 2 2 2 2 0 3 1 
200  70 
 
SHAHADATH 
HOSSAIN 448633G  49 1  2 2 2 2 2 2 0 1 1 
201  71 
 
AJOY PAUL 602120G  60 1  2 2 2 2 2 2 0 1 1 
202  72 
 
LAKSHI K 761804G  37 2  2 2 2 2 2 2 0 4 2 
203  73 
 
MD MIJANUR 
RAHMAN 761801G  38 1  2 2 2 2 2 2 0 12 2 
204  74 
 
ARCHANA DAS 313505F  47 2  1 1 2 2 2 2 0 10 1 
205  75 
 
UMAMAGHESWARI 406135C  34 2  2 1 2 2 2 2 0 10 2 
206  76 
 
NIRMALA K 042368F  48 2  2 2 2 2 2 2 0 2 1 
207  77 
 
AMUDHAVELU K 773793C  40 1  2 2 2 2 2 2 0 2 1 
208  78 
 
SONY CYR 680376G  50 1  2 2 2 2 2 2 0 2 1 
209  79 
 
PRABHU KUMAR 
MEHTA 499125G  38 1  2 2 2 2 2 2 0 1 1 
210  80 
 
JAYAKUMAR S 479406G  41 1  2 2 2 2 2 2 0 5 1 
211  81 
 
MANGAI R 463968G  48 2  2 2 2 2 2 2 0 1 1 
212  82 
 
BISWARUP 
SAMANTA 475031G  37 1  2 2 2 2 2 2 0 1 3 
112 
 
213  83 
 
DIPAK MONDAL 614109G  47 1  2 2 2 2 2 2 0 1 1 
214  84 
 
ANAKHI RANI SUR 481311G  39 2  2 2 2 2 2 2 0 3 1 
215  85 
 
KAMAL ROY 
CHOWDHURY 778848G  52 1  2 2 2 2 2 2 0 3 2 
216  86 
 
KUMARI M 022981D  35 2  2 2 2 2 2 2 0 2 1 
217  87 
 
VIJY KUMAR 
PANDEY 813896G  53 1  2 2 2 2 1 2 3 4 3 
218  88 
 
NAOMI ABRAHAM 060816F  52 2  2 2 2 2 2 2 0 1 1 
219  89 
 
DIPA BANERJEE 382526G  43 2  2 2 2 2 2 2 0 2 1 
220  90 
 
PRAVASH KUMAR 
SINGH 496613G  41 1  2 2 2 2 2 2 0 2 1 
221  91 
 
LAKSHMI DEVI 519685F  55 2  2 2 2 2 2 2 0 6 1 
222  92 
 
KASHINATH 
MONDAL 717843G  65 1  2 2 2 2 2 2 0 2 1 
223  93 
 
INDRANIL DEY 422017G  29 1  2 2 2 2 2 2 0 1 2 
224  94 
 
MD YAQOOB 760959G  67 1  2 2 2 2 2 2 0 1 1 
225  95 
 
SELVARAJ K 659666G  59 1  2 2 2 2 1 2 2 15 1 
226  96 
 
GUNAVATHI C 317426F  57 2  2 2 2 2 2 2 0 5 2 
227  97 
 
NIRMALA BAI 759672G  51 2  2 2 2 2 2 2 0 2 1 
228  98 
 
GANTA 
RAMACHANDRAN D 928866D  59 1  2 2 2 2 2 2 0 1 1 
229  99 
 
CHETNA CHANICHAL 699011G  40 2  2 2 2 2 2 2 0 1 1 
230  100 
 
RAMU A 703322A  52 1  2 2 2 2 2 2 0 2 3 
231  101 
 
MINUBHA SAIKIA 807153G  52 2  2 2 2 2 2 2 0 7 1 
232  102 
 
SHELLEY C V 908345A  51 2  2 2 2 2 2 2 0 1 1 
233  103 
 
MD FERDOUS RANA 862434G  52 1  2 2 2 2 2 2 0 1 1 
234  104 
 
DEEPA R 117854D  32 2  2 2 2 2 2 2 0 1 1 
235  105 
 
PRABHAKAR J A 165122B  70 1  2 2 2 2 2 2 0 1 1 
236  106 
 
GANDHIMATHY C 227221D  45 2  2 2 2 2 2 2 0 4 2 
237  107 
 
TAPAS SIKDAR 408820G  41 1  2 2 2 2 2 2 0 2 1 
238  108 
 
ANIL HALDAR 445774G  66 1  2 2 2 2 2 2 0 1 1 
239  109 
 
PRADIP KUMAR 427791G  45 1  2 2 2 2 1 1 12 12 1 
240  110 
 
AWDHESH KUMAR 756407G  48 1  2 2 2 2 2 2 0 1 1 
241  111 
 
NIDHI KUMARI 495017G  31 2  2 2 2 2 2 2 0 1 1 
242  112 
 
ABDUL HAI 
CHOWDHURY 671593G  65 1  2 2 2 2 2 2 0 1 1 
243  113 
 
MUKTI SAHA 713433G  54 2  2 2 2 2 2 2 0 6 1 
244  114 
 
NAIUM HUSSAIN 660686G  22 1  2 2 2 2 2 2 0 3 2 
245  115 
 
SHANTHI G 122062F  48 2  2 2 2 2 2 2 0 2 1 
246  116 
 
MANOJ KUAR SINGH 487469G  39 1  2 2 2 2 2 2 0 1 1 
247  117 
 
MOHAMED IMRAN 776835G  26 1  2 2 2 2 2 2 0 3 1 
248  118 
 
NIMAY BAURI 180445G  43 1  2 2 2 2 2 2 0 4 1 
249  119 
 
SAIKET HALDER 766360G  31 1  1 1 2 2 2 2 0 5 1 
250  120 
 
SONA SAW 755535G  61 1  2 2 2 2 2 2 0 8 1 
251  121 
 
SUPRITY DAS 342961G  36 2  2 2 2 2 2 2 0 2 1 
252  122 
 
SUDHANSHU 
PRASAD 408789G  53 1  2 2 2 2 2 2 0 1 1 
253  123 
 
MD FARUK HOSSEN 489054G  37 1  2 2 2 2 2 2 0 1 1 
254  124 
 
SAHANA DATTA 306078G  52 2  2 2 2 2 2 2 0 2 1 
255  125 
 
KAJAL DEY 764981G  59 1  2 2 2 2 2 2 0 2 1 
113 
 
256  126 
 
BANERJEE P K 819347G  63 1 4 2 2 2 2 2 2 0 5 2 
257  127 
 
CHAMPA DEVI 486252G  31 2  2 2 2 1 2 2 0 4 1 
258  128 
 
HARU BISWAS 796420G  56 1  2 2 2 2 2 2 0 12 1 
259  129 
 
JOY DEV GHORAI 456429C  47 1  2 2 2 2 2 2 0 10 3 
260  130 
 
STIFAN DAIMARI 431210G  65 1  2 2 2 2 2 2 0 1 1 
 
